Spinal Dynamics Corp.
This article was originally published in Start Up
Spinal Dynamics Corp. hopes that its spinal disc replacement system will simulate the cushioning function of a normal disc, to restore a patient's normal movement and prevent the degeneration of adjacent discs.
You may also be interested in...
Medtronic recently declared that InFUSE, the company's blockbuster spine bone graft product that provides the growth factor rhBMP-2 as part of a lumbar fusion cage, was well on its way to becoming standard of care in spine surgery. The company's success has fueled interest in a plethora of potential entrants into the biologic bone formation market.
In recent years, few technology areas in orthopedics have stimulated more debate than spine, and at the head of the controversy, as evidenced by this year's annual meeeting of the American Academy of Orthopedic Surgeons, is disc replacement.
Spine arthroplasty--replacing either the entire disc or simply the nucleus--is one of the most promising new therapies to treat patients with herniated discs and degenerative disc disease. But the technology has had a rocky history: rushed into patients too soon, without proper clinical trials, say critics, disc replacement languished in Europe and took a long time to attract interest in the US. Moreover, first generation arthroplasty products, most notably discs, had several drawbacks that limited adoption--some were very hard to implant, for example, while others were too stiff and tended to extrude. Companies like Disc Dynamics hope to ride the wave of interest in disc and nucleus replacement as it develops new technology that is both superior to first generation products and backed by the proper kinds of clinical studies.